Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chunxia Su

Showing results (11-20 of 222) with videos related to

Pageof 23
Sort By:
Current Cancer Drug Targets|March 17, 2021
Role of Aberrant Lipid Metabolism of Cancer Stem Cells in Cancer ProgressionJuan Zhou, Jing Zhao, Chunxia Su
Cancer Drug Resistance (Alhambra, Calif.)|May 18, 2022
Immunotherapy resistance of lung cancerXin Yu, Chaonan Han, Chunxia Su
Current Opinion in Oncology|November 2, 2022
Progress in diagnosis and treatment of checkpoint inhibitor pneumonitisXin Yu, Jing Wu, Chunxia Su
Pharmaceutics|August 26, 2022
Recent Advances in Nanoparticles-Based Platforms Targeting the PD-1/PD-L1 Pathway for Cancer TreatmentXin Yu, Chao Fang, Kun Zhang, et al.
Thoracic Cancer|June 6, 2020
Association of CD8 T cell apoptosis and EGFR mutation in non-small lung cancer patientsChao Zhao, Chunxia Su, Xuefei Li, et al.
Medical Oncology (Northwood, London, England)|August 18, 2010
Serum cytokine levels in patients with advanced non-small cell lung cancer: correlation with treatment response and survivalChunxia Su, Caicun Zhou, Songwen Zhou, et al.
Heliyon|April 1, 2024
Identification of nomogram associated with durable clinical benefit gene for advanced non-small cell lung cancer with sensitivity to responsive to immunotherapyLi Wang, Xiangling Chu, Xin Yu, et al.
The Clinical Respiratory Journal|November 27, 2014
Hyperpigmentation in palms associated with lung adenocarcinoma resolving after chemotherapyFengying Wu, Chunxia Su, Li Liu, et al.
Revista Da Escola De Enfermagem Da U S P|March 6, 2025
Effect of psychological intervention combined with feedback-based health education on lung cancer patientsYing Huang, Xiaoxiao Xu, Feifei Weng, et al.
Translational Lung Cancer Research|June 15, 2026
The role of tumor metabolic reprogramming in acquired anti-PD-1/PD-L1 resistanceCize Gao, Jianing Chen, Boyue Pang, et al.
Pageof 23

Showing results (11-20 of 222) with videos related to

Sort By:
Pageof 23
Current Cancer Drug Targets|March 17, 2021
Role of Aberrant Lipid Metabolism of Cancer Stem Cells in Cancer ProgressionJuan Zhou, Jing Zhao, Chunxia Su
Cancer Drug Resistance (Alhambra, Calif.)|May 18, 2022
Immunotherapy resistance of lung cancerXin Yu, Chaonan Han, Chunxia Su
Current Opinion in Oncology|November 2, 2022
Progress in diagnosis and treatment of checkpoint inhibitor pneumonitisXin Yu, Jing Wu, Chunxia Su
Pharmaceutics|August 26, 2022
Recent Advances in Nanoparticles-Based Platforms Targeting the PD-1/PD-L1 Pathway for Cancer TreatmentXin Yu, Chao Fang, Kun Zhang, et al.
Thoracic Cancer|June 6, 2020
Association of CD8 T cell apoptosis and EGFR mutation in non-small lung cancer patientsChao Zhao, Chunxia Su, Xuefei Li, et al.
Medical Oncology (Northwood, London, England)|August 18, 2010
Serum cytokine levels in patients with advanced non-small cell lung cancer: correlation with treatment response and survivalChunxia Su, Caicun Zhou, Songwen Zhou, et al.
Heliyon|April 1, 2024
Identification of nomogram associated with durable clinical benefit gene for advanced non-small cell lung cancer with sensitivity to responsive to immunotherapyLi Wang, Xiangling Chu, Xin Yu, et al.
The Clinical Respiratory Journal|November 27, 2014
Hyperpigmentation in palms associated with lung adenocarcinoma resolving after chemotherapyFengying Wu, Chunxia Su, Li Liu, et al.
Revista Da Escola De Enfermagem Da U S P|March 6, 2025
Effect of psychological intervention combined with feedback-based health education on lung cancer patientsYing Huang, Xiaoxiao Xu, Feifei Weng, et al.
Translational Lung Cancer Research|June 15, 2026
The role of tumor metabolic reprogramming in acquired anti-PD-1/PD-L1 resistanceCize Gao, Jianing Chen, Boyue Pang, et al.
Pageof 23